Verified July 2026 · Cited to primary sources
Retatrutide vs MOTS-c — evidence grades compared.
The honest verdict
Retatrutide has the stronger evidence (Grade B vs MOTS-c's Grade D).
Retatrutide wins on evidence: it is Grade B with published Phase 2 weight-loss data, while MOTS-c is Grade D (association-only). But retatrutide is investigational and not legally available, and MOTS-c has no proven weight-loss effect — so for weight loss you can actually access today, an approved GLP-1 beats both.
Retatrutide vs MOTS-c: side by side
| Compared on | Retatrutide | MOTS-c |
|---|---|---|
| Evidence grade | Grade B | Grade D |
| Legal status | Research-only | Under FDA review |
| Safety | Limited human safety data, no major documented harms | Limited human safety data, no major documented harms |
| Primary use | Weight Loss | Weight Loss |
| Typical cost | UNKNOWN (investigational — not commercially available) | UNKNOWN |
| One-line verdict | Retatrutide is investigational (Phase 3), not FDA-approved, and not legally available. Human evidence is Grade B — strong published Phase 2 weight-loss data, but not a finished approval. For proven weight loss you can access legally today, see our GLP-1 guidance. | MOTS-c is not FDA-approved and is under FDA review (July 23, 2026 PCAC). Human evidence is Grade D — metabolic effects are mostly preclinical, with human data limited to associations. For actual weight loss, an approved GLP-1 is the evidence-backed route. |
| Full review | Full Retatrutide review → | Full MOTS-c review → |
Grades and legal status are assigned by our evidence rubric, not by what we can sell. Highlighted cells mark the stronger-evidence side.
Trying to lose weight?
For weight loss, an approved GLP-1 beats either of these.
Neither peptide here has proven, legally-available weight-loss data that beats an approved GLP-1. Our sister site compares the options that actually work.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
Retatrutide vs MOTS-c FAQ
Is Retatrutide better than MOTS-c?
On strength of human evidence, Retatrutide grades higher (Grade B vs MOTS-c's Grade D). Retatrutide wins on evidence: it is Grade B with published Phase 2 weight-loss data, while MOTS-c is Grade D (association-only). But retatrutide is investigational and not legally available, and MOTS-c has no proven weight-loss effect — so for weight loss you can actually access today, an approved GLP-1 beats both.
Which has stronger human evidence, Retatrutide or MOTS-c?
Retatrutide has the stronger evidence (Grade B vs MOTS-c's Grade D). We grade every peptide A–F by strength of human evidence: Retatrutide is Grade B (real human trials, limited or historical) and MOTS-c is Grade D (animal studies only, unproven in humans).
Is Retatrutide or MOTS-c legal to get?
Retatrutide: no legal supervised us route (Not compoundable — research-only). MOTS-c: regulatory limbo — july 2026 pcac vote pending (Under FDA review — July 2026 PCAC). Always confirm current status with a licensed clinician before pursuing either — we don't link gray-market vendors.
Keep comparing
The monthly peptide evidence brief.
What the research and the FDA actually say — one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.